Showing results (291-300 of 365) with videos related to
Sort By:
Pageof 37
Cancer Chemotherapy and Pharmacology|October 27, 1998
High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinicallyP N Lara, D R Gandara, G T Wurz, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2017
Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance)Maria Q Baggstrom, Mark A Socinski, Xiaofei F Wang, et al.The Annals of Thoracic Surgery|August 30, 2008
Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancerMartin J Edelman, Mohan Suntharalingam, Whitney Burrows, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trialPasi A Jänne, Xiaofei Wang, Mark A Socinski, et al.Lung Cancer (Amsterdam, Netherlands)|January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancerJoe J Stephenson, John Nemunaitis, Anil A Joy, et al.International Journal of Molecular Sciences|July 15, 2026
Off-Target-Based Tumor Fraction Estimation from Targeted Sequencing Shows Concordance with Orthogonal Methods Across Advanced Solid TumorsSamantha O Hasenleithner, Shilpa Rao, Jian Q Yu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203Martin J Edelman, Dee Watson, Xiaofei Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapyJohan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.Scientific Reports|April 20, 2025
Winter activity of tricolored bats in aboveground and subterranean hibernacula in the southeastern USASusan C Loeb, William C Bridges, Eric A Winters, et al.JCO Precision Oncology|July 10, 2026
Pragmatic, Multicenter, Double-Blind Evaluation of Circulating Cancer-Associated Macrophage-Like Cells for Detection of Cancer in Indeterminate Pulmonary NodulesMartin J Edelman, Anil Vachani, Dana Marie Haagen Zambino, et al.Pageof 37